No Data
Anxusheng Biology (688075.SH) distributed earnings of 0.4 yuan per share for the first half of the year, with the registration date of November 8th.
Anxubio (688075.SH) announced that the company will implement the interim equity distribution for the first half of 2024, with a dividend per share...
Assure Tech (Hangzhou) Co., Ltd. (SHSE:688075) Insiders, Who Hold 39% of the Firm Would Be Disappointed by the Recent Pullback
Anxu Biotech: Anxu Biotech\'s 2024 Third Quarter Report
Anxu Biotech\'s 2024 Third Quarter Report
Anxusheng Biotechnology (688075.SH) released its performance for the first three quarters, with a net income of 0.136 billion yuan, a year-on-year decrease of 27.33%.
Anxubio (688075.SH) released the third quarter report for 2024, with a revenue of 4....
Anxusheng Biology (688075.SH): The net income in the first three quarters was 0.136 billion yuan, a year-on-year decrease of 27.33%.
On October 30, Aushun Biology (688075.SH) announced that in the first three quarters of 2024, it achieved total operating income of 0.403 billion yuan, a year-on-year increase of 27.56%; net income attributable to the parent company's shareholders was 0.136 billion yuan, a year-on-year decrease of 27.33%; basic earnings per share was 1.07 yuan.
No Data
